News About: Pharm. Industry
Modified new drugs made great market success.
A modified new drug market shows a rapid growing in Korea, indicating an ideal answer to explore for further business progress for the local drug industry where the piple line products and R&D capability were vulnerab...
Daewoong to beef up OTC sales
Daewoong Pharm will beef up its OTC sales from this July by strengthening its ties with associated wholesalers, according to marketing sources on June 28.
To that end, the company will additionally increase the num...
Namyang Drug purchases large distribution center
Namyang Drug, a leading hospital-oriented wholesaler, said on June 19 it has purchased a large drug distribution center in a bid to meet fierce competition in the domestic distribution market.
The distribution cent...
Local pharmaceutical industry to eye on African markets.
The African drug market has come up as a new rising target for the local drug industry to explore a strategy to overcome the already saturated local marketability by shifting their major markets from the South East As...
SK Chemicals to introduce Toray's TRK-820SK Chemicals announced on June 27 that it has concluded a licensing agreement with Toray Inc. of Tokyo, Japan, for the introduction of TRK-820 (nalfurafine HCl).
TRK-820 is a...
|
Korea seeks drug research with China and North KoreaSeven institutes from Korea, China and North Korea signed a memorandum of understanding to broaden joint research endeavors in Seoul, industries sources on June 27.
The joini...
|
AstraZeneca Korea opposes price reduction of Iressa
AstraZeneca Korea filed comments against the government's demand of price readjustment on the cancer drug Iressa (genfitinib) following a civic group's petition last March.
In its petition, the Health World Network...
Korea's new drugs advancing into 2005 output of 100 finished items
Domestically developed new drugs Dong's Stillen capsule, SK's Joins tablet, and Yuyu's Maxmarvil tablet ranked in 2005 output of Korea's top 100 finished drugs, according to data released by the Korea Pharmaceutical...
Daewoong eyes establishment of new scientific awardDaewoong Pharm and Korean Dermatological Association agreed to give a new Scientific Award in a bid to promote the scientific research in the domestic dermatological field for b...
|
Additional indication for Revanex granted
The Korean Food and Drug Administration (KFDA) said on June 26 it has granted Yuhan Corp. an additional indication for their novel proton pump inhibitor Revanex (revaprazan).
Revanex is now indicated for the preven...
